Although mGluR4 expression is positively correlated with high‐grade bladder cancer (BCa), functional activation of mGluR4 inhibits proliferation and augments apoptosis through the cAMP/PTEN/AKT signaling pathway, thereby inhibiting BCa development [86]. Here, GRM4 is linked to urinary bladder carcinoma.